bioAffinity Technologies, Inc. Quarterly Return On Equity in % from Q4 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
bioAffinity Technologies, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2022 to Q2 2024.
  • bioAffinity Technologies, Inc. Return On Equity for the quarter ending June 30, 2024 was -170 %, a 78.5% decline year-over-year.
  • bioAffinity Technologies, Inc. annual Return On Equity for 2023 was -107 %, a 132% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -170 -74.8 -78.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -133 +66.1 +33.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -107 -438 -132% Oct 1, 2023 Dec 31, 2023
Q3 2023 -80.9 Jul 1, 2023 Sep 30, 2023
Q2 2023 -95.3 Apr 1, 2023 Jun 30, 2023
Q1 2023 -199 Jan 1, 2023 Mar 31, 2023
Q4 2022 330 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.